MannKind develops dry powder inhaler for pulmonary hypertension treatment

Go back to MannKind develops dry powder inhaler for pulmonary hypertension treatment
Mannkind Corporation (NASDAQ: MNKD) Delayed: 4.11 +0.22 (5.66%)
Previous Close $3.89    52 Week High $2.51 
Open $3.91    52 Week Low $0.41 
Day High $4.15    P/E N/A 
Day Low $3.85    EPS $-0.64 
Volume 5,047,822       

United Therapeutics Corp (NASDAQ: UTHR) Delayed: 538.84 +5.90 (1.11%)
Previous Close $532.94    52 Week High $164.04 
Open $534.84    52 Week Low $97.52 
Day High $541.03    P/E 98.51 
Day Low $524.58    EPS $5.47 
Volume 1,198,818